Cornerstone Capital Management Holdings’s Achieve Life Sciences ACHV Stock Holding History

Cornerstone Capital Management Holdings’s Portfolio ACHV Stock Details ACHV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-6	Closed	-$31K	–	1367
2014 Q4	$31K	Hold	6	–	–	﹤0.01%	1222
2014 Q3	$36K	Hold	6	–	–	﹤0.01%	1226
2014 Q2	$50K	Sell	6 -2	-25%	-$24.6K	﹤0.01%	1242
2014 Q1	$212K	Hold	8	–	–	﹤0.01%	1107
2013 Q4	$145K	Buy	+8	New	+$140K	﹤0.01%	1091

Other funds holding ACHV

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Allianz Asset Management Munich, Germany $123B AUM 45.23% 1-Year Est. Return

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $52.8B AUM 58.98% 1-Year Est. Return

BlackRock Group London, United Kingdom $210B AUM 15.5% 1-Year Est. Return

Cornerstone Capital Management Holdings's ACHV Position: Q1 2015 in Review

Cornerstone Capital Management Holdings sold out of Achieve Life Sciences (ACHV) in Q1 2015, closing a stake of 6 shares — an estimated $31K sold.

Cornerstone Capital Management Holdings first reported a position in ACHV in Q4 2013 and held it in 5 quarters. The position peaked at $212K in Q1 2014. 49 funds tracked by Wall St. Rank hold ACHV as of Q1 2015.

Cornerstone Capital Management Holdings reported no remaining Achieve Life Sciences position as of Q1 2015 after selling out during the quarter.
Cornerstone Capital Management Holdings sold 6 Achieve Life Sciences shares in Q1 2015, an estimated $31K.
Cornerstone Capital Management Holdings first reported a position in Achieve Life Sciences in Q4 2013 and held it in 5 quarters.
Cornerstone Capital Management Holdings's Achieve Life Sciences position peaked at $212K in Q1 2014.
49 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q1 2015.

Based on Cornerstone Capital Management Holdings's 13F filing for Q1 2015, filed 24 Apr 2015.